Q2 2026 Holdings
Filed 2026-08-13 | 30 holdings | $509.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $58.7M | 918,070 | 11.5% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $55.8M | 2,984,125 | 11.0% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $44.7M | 1,376,159 | 8.8% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $44.2M | 6,391,328 | 8.7% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $35.7M | 1,353,047 | 7.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $34.6M | 354,816 | 6.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $28.5M | 543,876 | 5.6% |
| Savara Inc(SVRA) | COM | 805111101 | $21.3M | 3,452,576 | 4.2% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $17.8M | 306,047 | 3.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $16.7M | 329,006 | 3.3% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $15.9M | 1,088,731 | 3.1% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $12.6M | 3,693,931 | 2.5% |
| Inflarx NV(IFRX) | COM | N44821101 | $12.0M | 5,352,198 | 2.4% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $11.2M | 432,040 | 2.2% |
| Alumis Inc(ALMS) | COM | 022307102 | $11.0M | 392,574 | 2.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $9.9M | 4,059,054 | 2.0% |
| Minerva Neurosciences Inc(NERV) | COM NEW | 603380205 | $9.2M | 1,655,500 | 1.8% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $8.6M | 2,198,502 | 1.7% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $8.0M | 1,661,073 | 1.6% |
| Erasca Inc(ERAS) | COM | 29479A108 | $7.7M | 422,543 | 1.5% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $7.3M | 3,581,603 | 1.4% |
| Research Alliance Corp III | ORD SHS CL A | G75226103 | $5.4M | 500,000 | 1.0% |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | $5.3M | 500,000 | 1.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $5.3M | 279,110 | 1.0% |
| Achieve Life Science Inc(ACHV) | COM | 004468500 | $4.8M | 736,637 | 0.9% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $4.3M | 928,593 | 0.8% |
| Alector Inc(ALEC) | COM | 014442107 | $4.2M | 2,101,068 | 0.8% |
| Leonabio Inc(LONA) | COM | 04746L203 | $3.6M | 393,701 | 0.7% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $3.5M | 231,585 | 0.7% |
| Jatt II Acquisition Corp | ORD SHS | G50765109 | $1.8M | 160,000 | 0.4% |